Article Discusses the Benefits, Operation and Use of Ultracapacitors by Leading Ultracapacitor Companies

Enable IPC Corporation (PINKSHEETS: EIPC) today announced that the cover story of the April 2009 edition of the American Ceramic Society Bulletin features Enable IPC's SolRayo subsidiary. The Bulletin is a monthly magazine that provides information to professionals in the ceramics community worldwide.

The article, titled "A Heroic Capacity," discusses how ultracapacitors complement batteries, and how several of the leading ultracapacitor companies, including SolRayo, are working to integrate their use in various applications. The article can be found at: http://www.americanceramicsociety.org/bulletin/apr_09/.

In the article, Kevin Leonard, SolRayo Chief Technology Officer, explains that one of the primary keys to making ultracapacitors work in renewable energy applications is cost. The Enable IPC/SolRayo technology lowers the "energy storage per dollar" cost by using nanoparticulate sand in conjunction with low cost carbon electrodes, boosting capacitance.

Technical details on these issues and the Company's solutions can be found at: http://www.solrayo.com/SolRayo/Ultracapacitor/Entries/2008/4/12_SolRayos_Ultracapacitor_Research.html.

Separately, Enable IPC recently announced the shipment of ultracapacitor electrodes to IMDEA in Madrid. This contract is in connection with a high profile renewable energy demonstration project in Spain.

Additionally, Kevin Leonard and Dr. Mark Daugherty (SolRayo's President) led a Webinar in January on the use of ultracapacitors in renewable energy. This presentation is available online at: http://www.solrayo.com/SolRayo/Renewable_Energy_Slides.html#0.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.